"Cholangitis, Sclerosing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chronic inflammatory disease of the BILIARY TRACT. It is characterized by fibrosis and hardening of the intrahepatic and extrahepatic biliary ductal systems leading to bile duct strictures, CHOLESTASIS, and eventual BILIARY CIRRHOSIS.
Concept/Terms
Cholangitis, Sclerosing- Cholangitis, Sclerosing
- Cholangitides, Sclerosing
- Sclerosing Cholangitides
- Sclerosing Cholangitis
- Cholangiitis, Sclerosing
- Cholangiitides, Sclerosing
- Sclerosing Cholangiitides
- Sclerosing Cholangiitis
Below are MeSH descriptors whose meaning is more general than "Cholangitis, Sclerosing".
Below are MeSH descriptors whose meaning is more specific than "Cholangitis, Sclerosing".
This graph shows the total number of publications written about "Cholangitis, Sclerosing" by people in Harvard Catalyst Profiles by year, and whether "Cholangitis, Sclerosing" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1996 | 0 | 2 | 2 |
1998 | 2 | 0 | 2 |
1999 | 2 | 0 | 2 |
2003 | 1 | 0 | 1 |
2005 | 2 | 2 | 4 |
2006 | 1 | 0 | 1 |
2007 | 2 | 1 | 3 |
2008 | 1 | 0 | 1 |
2009 | 1 | 3 | 4 |
2010 | 1 | 2 | 3 |
2011 | 2 | 2 | 4 |
2012 | 2 | 0 | 2 |
2013 | 2 | 1 | 3 |
2014 | 5 | 1 | 6 |
2015 | 2 | 2 | 4 |
2016 | 3 | 0 | 3 |
2017 | 6 | 0 | 6 |
2018 | 4 | 3 | 7 |
2019 | 9 | 0 | 9 |
2020 | 4 | 1 | 5 |
2021 | 11 | 1 | 12 |
2022 | 3 | 0 | 3 |
2023 | 6 | 0 | 6 |
2024 | 1 | 0 | 1 |
Below are the most recent publications written about "Cholangitis, Sclerosing" by people in Profiles.
-
African American race does not confer an increased risk of clinical events in patients with primary sclerosing cholangitis. Hepatol Commun. 2024 Feb 01; 8(2).
-
Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with Cholangiocarcinoma. Cancer Epidemiol Biomarkers Prev. 2023 10 02; 32(10):1338-1347.
-
Beyond genome-wide association studies: Investigating the role of noncoding regulatory elements in primary sclerosing cholangitis. Hepatol Commun. 2023 10 01; 7(10).
-
Bile acid-induced IRF3 phosphorylation mediates cell death, inflammatory responses, and fibrosis in cholestasis-induced liver and kidney injury via regulation of ZBP1. Hepatology. 2024 Apr 01; 79(4):752-767.
-
PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitis. BMC Gastroenterol. 2023 Mar 15; 23(1):75.
-
Navigating the Challenges Associated With a Diagnosis of Autoimmune Pancreatitis and IgG4-Related Sclerosing Cholangitis. Arch Pathol Lab Med. 2023 03 01; 147(3):283-293.
-
Adult Primary Sclerosing Cholangitis (PSC) subjects have worse biliary disease at diagnosis compared to pediatric PSC subjects. Clin Imaging. 2023 May; 97:7-13.
-
Persistent Cholestatic Injury and Secondary Sclerosing Cholangitis in COVID-19 Patients. Arch Pathol Lab Med. 2022 10 01; 146(10):1184-1193.
-
Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis. Abdom Radiol (NY). 2023 01; 48(1):151-165.
-
Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study. United European Gastroenterol J. 2022 03; 10(2):212-224.